Similar articles

• High-dose therapy in breast cancer: out of favor but not out of promise.

  Glück S, Stewart D. Glück S, et al. Bone Marrow Transplant. 2000 May;25(10):1017-9. doi: 10.1038/sj.bmt.1702388. Bone Marrow Transplant. 2000. PMID: 10828859
• Dose intensity studies in breast cancer--autologous bone marrow transplantation.

  Hortobagyi GN, Dunphy F, Buzdar AU, Spitzer G. Hortobagyi GN, et al. Prog Clin Biol Res. 1990;354B:195-209. Prog Clin Biol Res. 1990. PMID: 2236166 Review. No abstract available.
• High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.

  Smith GA, Henderson IC. Smith GA, et al. Important Adv Oncol. 1995:201-14. Important Adv Oncol. 1995. PMID: 7672807 Review. No abstract available.
• [High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].

  Nielsen DL, Svane IM. Nielsen DL, et al. Ugeskr Laeger. 2004 Nov 8;166(46):4148-50. Ugeskr Laeger. 2004. PMID: 15565849 Danish. No abstract available.
• High-dose chemotherapy and autologous bone marrow support for breast cancer.

  Peters WP. Peters WP. Important Adv Oncol. 1991:135-50. Important Adv Oncol. 1991. PMID: 1869274 Review. No abstract available.